抗淋球菌CMP-非ulosonate疗法的疗效依赖cathelicidins
本研究探索CMP-非ulosonate(CMP-NulO)类似物治疗淋球菌感染的作用机制。在小鼠阴道定植模型中,CMP-Kdn和CMP-Leg5,7Ac2的疗效在补体C1q-/-和C3-/-小鼠中仍保留,但在Camp-/-小鼠中丧失,表明cathelicidins介导其疗效。体外实验显示LOS上的Neu5Ac(而非Leg5,7Ac2或Kdn)赋予对cathelicidins LL-37和鼠CRAMP的抗性。
要点
- CMP-NulO疗效不依赖补体,而依赖cathelicidins。
- LOS Neu5Ac赋予对LL-37和鼠CRAMP的抗性。
- CMP-NulO在Camp-/-小鼠中无效。
核心结论
- CMP-NulO治疗淋球菌感染的疗效主要由cathelicidins介导,而非补体途径。
研究设计与样本
- 采用小鼠阴道定植模型,比较CMP-NulO在野生型、补体C1q-/-、C3-/-和Camp-/-小鼠中的疗效,并进行体外杀菌实验。
主要发现
- CMP-NulO在补体C1q-/-和C3-/-小鼠中仍有效。
- CMP-NulO在Camp-/-小鼠中无效。
- LOS Neu5Ac而非Leg5,7Ac2或Kdn在体外赋予对LL-37和鼠cathelicidin相关抗菌肽的抗性。
临床怎么用
- 提示CMP-NulO类疗法的抗菌机制依赖宿主cathelicidins,未来临床开发需考虑宿主cathelicidin水平对疗效的影响。
局限性
- 研究仅基于小鼠模型和体外实验,尚未在人体中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Novel therapies to counteract multidrug-resistant gonorrhea are urgently needed. A unique gonococcal immune evasion strategy involves capping of lipooligosaccharide (LOS) with sialic acid by gonococcal sialyltransferase (Lst), utilizing host-derived CMP-sialic acid (CMP-Neu5Ac in humans). LOS sialylation renders gonococci resistant to complement and cationic peptides, and down-regulates the inflammatory response by engaging siglecs. CMP-sialic acid analogs (CMP-nonulosonates [CMP-NulOs]) such as CMP-Leg5,7Ac2 and CMP-Kdn are also utilized by Lst. Incorporation of these NulO analogs into LOS maintains gonococci susceptible to complement. Intravaginal administration of CMP-Kdn or CMP-Leg5,7Ac2 attenuates gonococcal colonization of mouse vaginas. Here, we identify a key mechanism of action for the efficacy of CMP-NulOs. Surprisingly, CMP-NulOs remained effective in complement C1q-/- and C3-/- mice. LOS Neu5Ac, but not Leg5,7Ac2 or Kdn, conferred resistance to the cathelicidins LL-37 (human) and mouse cathelicidin-related antimicrobial peptide in vitro. CMP-NulOs were ineffective in Camp-/- mice, revealing that cathelicidins largely mediate the efficacy of therapeutic CMP-NulOs.
引用
- Gulati S, Schoenhofen IC, Lindhout-Djukic T, et al. Efficacy of Antigonococcal CMP-Nonulosonate Therapeutics Require Cathelicidins. J Infect Dis. 2020. PMID: 32692363. doi:10.1093/infdis/jiaa438
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。